Literature DB >> 7896265

Genomic structure of the candidate proto-oncogene BCL3.

T W McKeithan1, H Ohno, J Dickstein, E Hume.   

Abstract

We previously reported the identification of a novel candidate proto-oncogene involved in the translocation t(14;19)(q32;q13) found in some cases of human B-cell chronic lymphocytic leukemia. This gene, BCL3, is a member of the I kappa B family, whose encoded proteins regulate the NF-kappa B family of transcription factors. Here we describe the genomic structure of BCL3. The gene contains nine exons, spanning 11.5 kb. In comparison to other members of the I kappa B family, there is a remarkable conservation of the exon-intron boundaries in relation to the coding sequences, consistent with an origin from a common ancestral gene. BCL3 is unusual in containing two CpG islands, a 5' island encompassing the first exon, the other lying within the gene. Southern blot analysis using methylation-sensitive restriction enzymes revealed that while the 5' CpG is unmethylated in all tissues tested, the degree of methylation of the internal CpG island varies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7896265     DOI: 10.1006/geno.1994.1588

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

Review 1.  Reappraisal of BCL3 as a molecular marker of anaplastic large cell lymphoma.

Authors:  Hitoshi Ohno; Momoko Nishikori; Yoshitomo Maesako; Hironori Haga
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

Review 2.  Bcl-3, a multifaceted modulator of NF-kappaB-mediated gene transcription.

Authors:  Scott Palmer; Youhai H Chen
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 3.  NF-κB, Mesenchymal Differentiation and Glioblastoma.

Authors:  Bakhtiar Yamini
Journal:  Cells       Date:  2018-08-31       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.